702
Participants
Start Date
February 12, 2018
Primary Completion Date
March 9, 2023
Study Completion Date
March 9, 2024
Dexamethasone
Active treatment with dexamethasone from randomisation (IV followed by oral according to disease severity at the start of treatment): Dexamethasone for intravenous injection and dexamethasone for oral ingestion
Placebo
Treatment with matched placebo: Standard saline for intravenous injection and placebo oral tablets containing cellulose
Hospital for Tropical Diseases, Ho Chi Minh City
Oxford University Clinical Research Unit, Ho Chi Minh City
Pham Ngoc Thach Hospital, Ho Chi Minh City
Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
OTHER
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
OTHER
Oxford University Clinical Research Unit, Vietnam
OTHER